Member Info for moreprofit

OK will have a read. I hope its twice as good though as currently the mcap is suggesting its twice the company over its main competitor which does cause reason for caution. If this company hits £1 it will be over 3 times the mcap of its main competitors so it needs to show some good fundamental reason for that. For now I keep my free carry in this and may add if further research suggests I should. Thanks.

Anyone know the difference to the brand of CBD products already on the market to what the Zoe brand 'Chill' has to offer?
When looking at the market cap of existing companies selling this type of product, Zoe is already twice their market cap. What justification can anyone give me why this company should be trading at twice the market cap of existing competition?

This will hit 81p and then the buys will come flodding back to push it back up. Be ready to reload guys, you get a gift of a second chance to buy back if you sold. If you are still in, hold and lower your averages at 81p if you can. And if you are looking to make a new position wait for 80's. Then chuck the kitchen sink at it, as it will motor back up

I have bought £10k in these already but bought in on technicals which look very good. Can someone enlighten me on what deal we are waiting for? What is the product range etc?

Thanks in advance

apologies for spelling mistakes, (patience not patients and spook not spoke)

Just to add to my previous comments below, AVCT whilst 64% of AVCT shares are owned by institutionals investors (including 13 top ones) which adds huge credibility to the avct investment case, 30 % is in hands of the general public, so we have a good spread here. However its easy to spoke general public investors, so expect this to have heavy pull backs on delays as the average joe investor is easily spooked and lack the patients of the big long term ii's. But when avct are in the nyct phase of rolling out their 'holy grail' rapid saliva based antigen test kit, this will bag more rapidly than their saliva test kit results. Added to the test kit is the potentail collaboration with a major pharma for the anti viral treatment for covid and thats not even mentioning the advanced chemo drug developments which is what this company is all about with their superior affirmer technolog. This will be a minimum of 300p by Xmas.

Of course Myles trades stock, everyone does! But he also holds long term on the decent companies like avct. If you want an idea how good an investment avct is, look at the investors backing it. Avct is still a small cap stock with huge mcap potential. Its got a variety of institutional investors who collectively own 64% of avacta This tells us that avct is seen as a credible investment amongst professional investors. Now what makes it even more interesting to note is that 13 top institutions have 50% in AVCT, which means that its not relying on one big investor propping it up. They clearly all want a peace of the avacta cake, and a very large cake it will be!

I would agree that 10p for the moment would be its upper limit untill next bit of positive news comes along. Like I said before, there is good support at the 7.16p area, so this is a strong buy in low 7's and I imagine given the strong possibility of positive news in the pipeline in the not to distant future, we will mantain a nice trading range betwen low 7's and high 9's. Any dip below this range will be heavily bought into, so I would definetely be holding onto a portion at these levels. I will tempted to trade this on the swings, selling some in high 9's and buying back on drops to low 7's. Easy money. Ultimately, I will always keep some in as news can come anytime on another contract talks. This company is in a market that is now beginning to take centre stage in drug development and it is well placed to make big strides forwards from here.

Also just to add, profit making comopanies are very rare on aim. This makes it in my view at current prices a very low risk high reward buy when balanced with future potential. Won't be long before we see recent highs of 17p + again. But for now, 10p will be ok for me. Great share for both traders and investors.

Todays news is of large strategic value to PYC and investors. This contract is onboarding a new very large client with a significant Oncology Arm to the business. It opens the door for many more contracts and gives PYC increased likely hood of a takeover. A big contract could still be in the pipeline with clients such as GSK and investors/traders can feel confident holding or entering at these levels as PYC is now operating at profit so reduced need in the short term at least for fund raising. Big support at 7.16p level, so I see this share ranging between 7s and 9s for a while untill next news comes along. Great company, making fantastic progress.

Technically this is set up perfectly for a rebound as it is having a deep pull back in a trend that is rising. Its taking a little longer than expected, but this will bounce up to 1.5p soon. Then onto 2p

What is this obessession with Riddler? The share has done what he said it would do from when it was under 2p. Its now over 4 times that price and was 8 times that earlier in the week. How can you blame him for a sell off from 17p? Its a joke. You want someone to tip a share at a cheap price and then moan when it rises. Every share on aim has a sell off from a big spike. If this share only hit 9p and tailed off to 8p, no one would complain. The fact it hit 17p and dropped back to 8's, then people moan!

I think a drop back to 1.4p after lunch and then a big finish to 1.8p!

Yeah we have resistance 1.6p mark. This will possibly retrace to 1.35p before another test. Shouldn't take long to break 1.6p though. A few more sessions maybe? Or maybe today or tomorrow? Either way, we will break it

Of course it will move north. It is on an upward trend, creating higher lows and higher highs. Yesterday it got a little carried away. But now we are at a more sensible price. 14p is probably going to be hit again later next week as thats the technical target. I can see 10.5p being hit soon though. We will bounce around 8.5 - 10.5p for a few sessions, then climb gradually back up. That high of 17p I wouldn't rule out being hit again in a couple of weeks. We are likely in talks with a big pharma like GSK. Even if the project isn't huge as a first contract, a project with the likes of GSK would be strategically a huge win and will likely lead to mant more and perhaps a high chance of a takeover. Then we see 30p +

Took a bit longer than expected, but tree shake done for sure now. New bottom is 8.5p. Now we test the technical resistance of 14p again

1.51 to sell to be more precise

Sorry my mistake, 1.5p to sell

1.54p to sell!!!!!

There is nothing wrong with this share. Its the way its traded that is the problem. Riddler tipped this at a very good price. Anyone investing without reading research, knowing placing history, fundamentals etc is not going to make the right decisions. The share is fine. The company is fine. The technology the company has developed for drug development is ahead of the game. When it drops, buy. When it rises sell some. And let the rest run. How hard can it be?